drugset / Trial / NCT06760455
A Safety and Tolerability Study of BPR-30221616 Injection in Healthy Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety, tolerability, pharmacokinetics、 pharmacodynamics and immunogenicity of BPR-30221616 in healthy subjects.
Timeline
- Start
- 2025-01-10
- Primary completion
- 2026-01-24
- Completion
- 2026-12-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BPR-30221616 | Unknown | — | Subcutaneous |
Indications
No indication recorded.